Lipoprotein(a) Interactions With Lipid and Nonlipid Risk Factors in Early Familial Coronary Artery Disease
- 1 November 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 17 (11) , 2783-2792
- https://doi.org/10.1161/01.atv.17.11.2783
Abstract
Abstract An interaction between high plasma lipoprotein(a) [Lp(a)], unfavorable plasma lipids, and other risk factors may lead to very high risk for premature CAD. Plasma Lp(a), lipids, and other coronary risk factors were examined in 170 cases with early familial CAD and 165 control subjects to test this hypothesis. In univariate analysis, relative odds for CAD were 2.95 ( P <.001) for plasma Lp(a) above 40 mg/dL. Nearly all the risk associated with elevated Lp(a) was found to be restricted to persons with historically elevated plasma total cholesterol (6.72 mmol/L [260 mg/dL] or higher) or with a total/HDL cholesterol ratio >5.8. Nonlipid risk factors were also found to at least multiply the risk associated with Lp(a). When Lp(a) was over 40 mg/dL and plasma total/HDL cholesterol >5.8, relative odds for CAD were 25 ( P =.0001) in multiple logistic regression. If two or more nonlipid risk factors were also present (including hypertension, diabetes, cigarette smoking, high total homocysteine, or low serum bilirubin), relative odds were 122 ( P −12 ). The ability of nonlipid risk factors to increase risk associated with Lp(a) was dependent on at least a mildly elevated total/HDL cholesterol ratio. In conclusion, high Lp(a) was found to greatly increase risk only if the total/HDL cholesterol ratio was at least mildly elevated, an effect exaggerated by other risk factors. Aggressive lipid lowering in those with elevated Lp(a) therefore appears indicated.Keywords
This publication has 90 references indexed in Scilit:
- Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)European Journal of Clinical Investigation, 1994
- Prevention of restenosis after percutaneous transluminal coronary angioplasty by reducing lipoprotein (a) levels with low-density lipoprotein apheresisThe American Journal of Cardiology, 1994
- Nutrient intake and progression of coronary artery diseaseThe American Journal of Cardiology, 1994
- Relation of coronary artery disease in women <60 years of age to the combined elevation of serum lipoprotein (a) and total cholesterol to high-density cholesterol ratioThe American Journal of Cardiology, 1993
- Lipoprotein(a) and apolipoproteins B and A-1 in children and coronary vascular events in their grandparentsThe Journal of Pediatrics, 1993
- Predictive value of apolipoproteins in a prospective survey of coronary artery disease in menThe American Journal of Cardiology, 1992
- Oxidation of lipoprotein Lp(a). A comparison with low-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery diseaseThe American Journal of Cardiology, 1990
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- Lipoprotein Lp(a). A risk factor for myocardial infarction.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988